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Background
The Type C coping style, characterized by nonrecognition
and nonexpression of negative emotions and dyssyn-
chrony between psychological and physiological
responses to stress, has been associated with disease pro-
gression in both cancer and HIV, as well as with unfavora-
ble immune parameters. The present study expands this
work to examine other theoretically maladaptive coping
patterns.
Methods
Participants were 273 HIV-positive adults (54% male,
94% African-American) recruited from inpatient and out-
patient units of an inner-city U.S. hospital. Coping was
assessed using the Temoshok Vignette Similarity Rating
Method, adapting the previous assessment to reflect addi-
tional coping constructs.
Results
Patients with a hopeless, emotionally despairing coping
style had lower CD4+ counts (r = -0.134, p = 0.05) and
higher VLs (r = 0.165, p = 0.03), and were more likely to
be hospitalized during the 6-month follow-up period
(t(60) = 1.876, p = 0.07). Patients with a hostile, angry
coping style had higher VLs (r = 0.179, p = 0.02) and were
more likely to be hospitalized during follow-up (t(74) =
1.89, p = 0.06). Patients with an ashamed, repressive cop-
ing style had lower CD4+ counts (r = -0.152, p = 0.026).
Differences in clinical outcomes could not be explained
by differences in medication adherence.
Conclusion
These findings suggest that psychological interventions to
modify maladaptive coping may have a positive impact
on disease outcomes, as well as psychosocial health.
from 2006 International Meeting of The Institute of Human Virology
Baltimore, USA. 17–21 November, 2006
Published: 21 December 2006
Retrovirology 2006, 3(Suppl 1):P65 doi:10.1186/1742-4690-3-S1-P65
<supplement> <title> <p>2006 International Meeting of The Institute of Human Virology</p> </title> <note>Meeting abstracts. A single PDF containing all abstracts in this Supplement is available <a href=" http://www.biomedcentral.com/content/files/pdf/1742-4690-3-S1-full.pdf ">here</a></note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-3-S1-info.pdf</url></supplement>
© 2006 Wald et al; licensee BioMed Central Ltd. 
